Multidomain structure of human kidney-type glutaminase(KGA/GLS) | |
Heteromer
| 137-643 | 2×04A; |
Assess |
Human glutaminase C (Y466W) with L-Gln and Pi, filamentous form | | homo-12-mer | 139-525 | 12×PO4; 12×GLN; |
Assess |
Crystal Structure of Human GAC in Complex with Glutamate and BPTES | | homo-4-mer | 136-560 | 4×GOL; 2×04A; |
Assess |
Human glutaminase C (Y466W) with L-Gln, closed conformation | | homo-4-mer | 134-546 | 4×GLN; |
Assess |
Crystal Structure of Human GAC in Complex with Glutamate | | homo-4-mer | 135-546 | 4×GLU; |
Assess |
Human GLS in complex with compound 12 | | homo-4-mer | 136-546 | 2×R90; |
Assess |
Crystal structure of glutaminase C in complex with inhibitor CB-839 | | homo-4-mer | 137-546 | 2×63J; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00023 | | homo-4-mer | 137-546 | 2×Q9M; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL_00009: 2-phenyl-~{N}-[5-[[(3~{R})-1-[… | | homo-4-mer | 137-546 | 2×5XX; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00013 | | homo-4-mer | 137-546 | 2×Q94; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL_00015: 2-phenyl-~{N}-[5-[(3~{S})-3-[[… | | homo-4-mer | 137-546 | 2×5XZ; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL_00011: 2-phenyl-~{N}-[5-[[(3~{S})-1-[… | | homo-4-mer | 137-546 | 2×5XY; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×QAM; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×QAA; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×QAJ; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×U27; |
Assess |
Room temperature serial crystal structure of Glutaminase C in complex with inhibitor UPGL-00004 | | homo-4-mer | 137-546 | 2×B4A; |
Assess |
Human glutaminase C (Y466W) with L-Gln, open conformation | | homo-4-mer | 137-546 | 4×GLN; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00018 | | homo-4-mer | 137-546 | 2×Q9S; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×QAJ; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×QA4; |
Assess |
Crystal structure of human glutaminase C in complex with the inhibitor UPGL-00019 | | homo-4-mer | 137-546 | 2×69V; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×Q9V; |
Assess |
Crystal structure of human GAC in complex with inhibitor UPGL00012 | | homo-4-mer | 137-546 | 2×Q9A; |
Assess |
Crystal Structure of human glutaminase with macrocyclic inhibitor | | homo-4-mer | 137-546 | 2×EN3; |
Assess |
Crystal structure of full length human glutaminase C expressed in E.coli | | homo-4-mer | 138-546 | |
Assess |
Room temperature serial crystal structure of Glutaminase C in complex with inhibitor BPTES | | homo-4-mer | 137-545 | 2×04A; |
Assess |
Crystal structure of glutaminase C in complex with compound 27 | | homo-4-mer | 138-545 | 2×V4I; |
Assess |
Crystal structure of glutaminase C in complex with compound 11 | | homo-4-mer | 138-544 | 2×V59; |
Assess |
Filament structure of GAC with phosphate | | homo-4-mer | 138-532 | 4×PO4; |
Assess |
Filament interface structure of GAC with phosphate | | homo-4-mer | 138-532 | 4×PO4; |
Assess |
Crystal structure of human glutaminase in apo form | | homo-4-mer | 221-533 | 8×SO4; |
Assess |
Human GLS in complex with compound 3 | | homo-4-mer | 222-532 | 36×SO4; 4×04A; |
Assess |
Crystal structure of human glutaminase in complex DON | | homo-4-mer | 221-531 | 4×ONL; |
Assess |
Crystal structure of human glutaminase in complex with L-glutamate and BPTES | | homo-4-mer | 221-531 | 4×04A; 4×GLU; 8×SO4; |
Assess |
Crystal structure of human glutaminase in complex with L-glutamine | | homo-4-mer | 221-531 | 4×GLN; 8×SO4; |
Assess |
Crystal structure of human glutaminase in complex with BPTES | | homo-4-mer | 221-531 | 4×04A; 8×SO4; |
Assess |
Crystal structure of human glutaminase in complex with inhibitor 4 | | homo-4-mer | 221-531 | 4×BP9; |
Assess |
Human GLS in complex with compound 27 | | homo-4-mer | 222-532 | 20×SO4; 4×R0C; |
Assess |
Crystal structure of human glutaminase in complex with inhibitor 2 | | homo-4-mer | 221-531 | 4×BP0; 4×SO4; |
Assess |
Crystal structure of human glutaminase in complex with inhibitor 3 | | homo-4-mer | 221-531 | 4×BP8; 4×SO4; |
Assess |
Allosteric inhibition of Kidney Isoform of Glutaminase | | homo-4-mer | 221-531 | 4×ZBS; |
Assess |
Human GLS in complex with compound 18 | | homo-4-mer | 222-532 | 20×SO4; 4×5XX; |
Assess |
Near full length Kidney type Glutaminase in complex with 2,2-Dimethyl-2,3-Dihydrobenzo[a] Phenanthr… | | homo-2-mer | 136-644 | 1×HZO; |
Assess |
Crystal structure of glutaminase C in complex with inhibitor 2-phenyl-N-{5-[4-({5-[(phenylacetyl)am… | | homo-2-mer | 137-546 | 2×B4A; |
Assess |
Crystal structure of human glutaminase in complex with L-glutamate | | homo-2-mer | 222-531 | 2×SO4; 2×GLU; 4×GOL; |
Assess |
C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - tetragonal crystal form | | homo-2-mer | 553-645 | 1×CL; 3×NA; |
Assess |
C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - monoclinic crystal form | | homo-2-mer | 553-642 | 3×NA; |
Assess |
Allosteric inhibition of Kidney Isoform of Glutaminase | | monomer | 221-531 | 1×63J; |
Assess |